tirzepatide availability fda 🚨 Alert: No Longer on FDA's Drug Shortage List As of October 2, 2024, the has announced that the Tirzepatide shortage has been resolved. This means that all doses of Lilly's Mounjaro receives FDA approval

Is This Right for You

How serious is alcoholic pancreatitis

These diverse actions make incretins valuable targets for therapeutic interventions in metabolic diseases like type 2 diabetes (Table 1)

Association of glucagon-like peptide 1 analogs and agonists administered for obesity with weight loss and adverse events: a systematic review and network meta-analysis

Tert-Butylhydroquinone alleviates insulin resistance and liver steatosis in diabetes

Valid reasons for switching include hitting a genuine plateau after months on stable dose, persistent side effects that do not resolve with time and management strategies, or availability and cost considerations that make the current peptide unsustainable